BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37185421)

  • 1. Seed Density as a New Predictive Index of Seed Migration in Brachytherapy for Prostate Cancer Using Iodine-125 Loose Seed.
    Yamaguchi T; Matsuo M; Mori T; Noda Y; Makita C; Hyodo F; Iinuma K; Nakano M; Koie T; Tanaka H
    Curr Oncol; 2023 Apr; 30(4):4060-4066. PubMed ID: 37185421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of seed migration to the chest, abdomen, and pelvis after transperineal interstitial prostate brachytherapy with loose (125)I seeds.
    Sugawara A; Nakashima J; Kunieda E; Nagata H; Mizuno R; Seki S; Shiraishi Y; Kouta R; Oya M; Shigematsu N
    Radiat Oncol; 2011 Oct; 6():130. PubMed ID: 21974959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study.
    Nakano M; Yorozu A; Saito S; Sugawara A; Maruo S; Kojima S; Kikuchi T; Fukushima M; Dokiya T; Yamanaka H
    Radiat Oncol; 2015 Nov; 10():228. PubMed ID: 26577301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds.
    Sugawara A; Nakashima J; Shigematsu N; Kunieda E; Kubo A
    Brachytherapy; 2009; 8(1):52-6. PubMed ID: 19154979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy.
    Hirose K; Aoki M; Sato M; Akimoto H; Hashimoto Y; Imai A; Kamimura N; Kawaguchi H; Hatayama Y; Fujioka I; Tanaka M; Ohyama C; Takai Y
    Jpn J Radiol; 2016 Nov; 34(11):718-723. PubMed ID: 27631882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing seed migration to near zero with stranded-seed implants: Comparison of seed migration rates to the chest in 1000 permanent prostate brachytherapy patients undergoing implants with loose or stranded seeds.
    Merrell KW; Davis BJ; Goulet CC; Furutani KM; Mynderse LA; Harmsen WS; Wilson TM; McLaren RH; Deufel CL; Birckhead BJ; Funk RK; McMenomy BP; Stish BJ; Choo CR
    Brachytherapy; 2019; 18(3):306-312. PubMed ID: 30853392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioactive seed migration after prostate brachytherapy with iodine-125 using loose seeds versus stranded seeds.
    Franca CA; Vieira SL; Carvalho AC; Bernabe AJ; Penna AB
    Int Braz J Urol; 2009; 35(5):573-9; discussion 579-80. PubMed ID: 19860936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is scintigraphy necessary to detect migration of 125I seeds after brachytherapy for early prostate cancer?
    Odagaki Y; Ohori M; Yoshimura M; Nakshima J; Ohno Y; Mikami R; Nakayama H; Tokuuye K; Tachibana M
    Int J Clin Oncol; 2016 Apr; 21(2):397-401. PubMed ID: 26394786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-125 thin seeds decrease prostate swelling during transperineal interstitial permanent prostate brachytherapy.
    Beydoun N; Bucci JA; Chin YS; Malouf D
    J Med Imaging Radiat Oncol; 2014 Feb; 58(1):109-16. PubMed ID: 24529064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Iodin 125 seed migration after prostate brachytherapy: a study of 170 patients].
    Chauveinc L; Osseili A; Flam T; Thiounn N; Rosenwald JC; Savignoni A; Cosset JM
    Cancer Radiother; 2004 Aug; 8(4):211-6. PubMed ID: 15450513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preimplant factors affecting prostate D90 after transperineal interstitial prostate brachytherapy with loose (125)I seeds.
    Sugawara A; Nakashima J; Kunieda E; Nagata H; Mizuno R; Takeda A; Seki S; Shiraishi Y; Kouta R; Oya M; Shigematsu N
    Keio J Med; 2012; 61(3):89-94. PubMed ID: 23018491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seed migration after transperineal interstitial prostate brachytherapy with I-125 free seeds: analysis of its incidence and risk factors.
    Miyazawa K; Matoba M; Minato H; Morita N; Chikazawa I; Ota K; Tokunaga K; Tonami H; Nojima T; Suzuki K
    Jpn J Radiol; 2012 Oct; 30(8):635-41. PubMed ID: 22798169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seed fixity in the prostate/periprostatic region following brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Lief JH; Benson ML
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):215-20. PubMed ID: 10656395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?
    Kudchadker RJ; Swanson DA; Kuban DA; Lee AK; Bruno TL; Frank SJ
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):623-7. PubMed ID: 18410998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migration of prostate brachytherapy seeds to the vertebral venous plexus.
    Nakano M; Uno H; Gotoh T; Kubota Y; Ishihara S; Deguchi T; Hayashi S; Matsuo M; Tanaka O; Hoshi H
    Brachytherapy; 2006; 5(2):127-30. PubMed ID: 16644468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvements in prostate brachytherapy dosimetry due to seed stranding.
    Lin K; Lee SP; Cho JS; Reiter RE; DeMarco JJ; Solberg TD
    Brachytherapy; 2007; 6(1):44-8. PubMed ID: 17284385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scintigraphic detection of 125I seeds after permanent brachytherapy for prostate cancer.
    Kono Y; Kubota K; Mitsumoto T; Tanaka A; Ishibashi A; Kobayashi K; Ito K; Itami J; Kanemura M; Minowada S
    J Nucl Med; 2008 Apr; 49(4):541-5. PubMed ID: 18344427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stranded seed displacement, migration, and loss after permanent prostate brachytherapy as estimated by Day 0 fluoroscopy and 4-month postimplant pelvic x-ray.
    Birckhead BJ; Fossum CC; Deufel CL; Furutani KM; Merrell KW; Schueler BA; Mynderse LA; Choo R; Davis BJ
    Brachytherapy; 2016; 15(6):714-721. PubMed ID: 27542893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy.
    Hirose K; Aoki M; Sato M; Akimoto H; Hashimoto Y; Imai A; Kamimura N; Kawaguchi H; Hatayama Y; Fujioka I; Tanaka M; Ohyama C; Takai Y
    Radiat Oncol; 2017 Dec; 12(1):192. PubMed ID: 29191234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Seed Migration Increase the Risk of Second Malignancies in Prostate Cancer Patients Treated With Iodine-125 Loose Seeds Brachytherapy?
    Vigneault E; Martell K; Taussky D; Husain S; Delouya G; Mbodji K; Piotte J; Magnan S; Després P; Lavallée MC; Aubin S; Beaulieu L; Foster W; Martin AG
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1190-1194. PubMed ID: 29428250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.